| Document Date: 2014-10-01 22:38:57
Open Document File Size: 332,65 KBShare Result on Facebook
Company Servier Laboratories / Type 2 Diabetes Introduction Servier Laboratories / Kempler / / Country Malaysia / Japan / India / / Holiday Ramadan / / IndustryTerm telephone authorities / diabetes treatment / / MedicalCondition non-insulin-dependent diabetes mellitus / diabetes FDC / diabetes / non-ST elevation Myocardial Infarction / Hypoglycemia / acute myocardial infarction / / MedicalTreatment oral therapy / insulin therapy / / Organization Pharmaceutical Benefits Advisory Committee / Drug Utilisation Subcommittee / International Diabetes Federation / / Person Aravind SR / Al Tayeb / Al Omari / Al Elq / Al Sifri / / Position General / / Product glimepiride / / PublishedMedium the European GUIDE / the DUSC review / / URL www.etg.org / /
SocialTag |
Servier Laboratories (Aust) Submission to Stage Three of the Review of Medicines Used in the Treatment of Type 2 Diabetes Introduction Servier Laboratories (Servier) is the sponsor of Diamicron MR (gliclazide 60mg modifi